Related Experiment Videos
Prognostic impact of stress testing in coronary artery disease
1CNR Clinical Physiology Institute, Pisa, Italy.
Insights
Patients not undergoing stress testing after coronary evaluation face higher mortality risk. Exercise electrocardiography is a validated tool for cardiac risk prognostication, with dipyridamole echocardiography showing promise as an alternative.
Area of Science:
- Cardiology
- Diagnostic Imaging
- Clinical Decision-Making
Background:
- Observational data allows examination of clinical decisions, including the omission of stress testing.
- Patients with coronary artery disease not undergoing stress testing due to clinical reasons exhibit higher mortality risk.
- Exercise electrocardiography is a well-validated tool for cardiac event prognostication across various patient groups.
Purpose of the Study:
- To evaluate the prognostic value of different stress testing modalities in patients with coronary artery disease.
- To compare the efficacy of exercise electrocardiography, radionuclide angiography, and dipyridamole echocardiography in risk stratification.
- To explore the potential of intravenous dipyridamole echocardiography as a diagnostic and prognostic tool.
Main Methods:
- Analysis of prospectively collected observational data.
- Review of studies validating exercise electrocardiography for risk stratification.
- Assessment of exercise radionuclide angiography and 201Tl scintigraphy for prognostication.
- Evaluation of preliminary data on intravenous dipyridamole echocardiography.
Main Results:
- Patients not receiving stress testing are at increased risk of death.
- Exercise electrocardiography accurately identifies low and high-risk patients.
- Exercise radionuclide angiography and 201Tl scintigraphy offer significant prognostic value but are costly.
- Intravenous dipyridamole echocardiography shows potential for diagnosis and prognostication, possibly independent of exercise electrocardiography.
Conclusions:
- Omission of stress testing in coronary evaluation is associated with higher mortality.
- Exercise electrocardiography remains a gold standard for cardiac risk prognostication.
- Intravenous dipyridamole echocardiography presents a promising, cost-effective alternative for diagnosis and prognostication, warranting further investigation.
Abstract:
Observational data prospectively collected permit the examination of a complex set of decisions, including the decision not to perform any stress testing. Patients with or without previous myocardial infarction admitted for coronary evaluation and not submitted to any stress testing because of clinical reasons are at a higher risk for subsequent death. For prognostication, no test has been better validated than exercise electrocardiography: it can identify patients at low and high risk for future cardiac events among those without symptoms, with typical chest pain, and with previous myocardial infarction. In patients with triple-vessel disease, the results of exercise also allow those at low and high risk to be recognized. Both exercise radionuclide angiography and 201Tl scintigraphy (the latter in larger patient populations) have also demonstrated significant prognostic value on patients with or without previous myocardial infarction. Neither one has shown superiority to the other in prognostication. So far, they have been considered the only viable alternatives to exercise electrocardiography stress testing for diagnosis and prognostication. However, their costs limit their extensive application. Preliminary data suggest that intravenous dipyridamole echocardiography can be used for both diagnosis and prognostication of coronary artery disease; moreover, the prognostic information derived from dipyridamole echocardiography testing seems independent of and additive to that provided by exercise electrocardiography. Further prospective studies on larger patient populations are needed to better define the prognostic value of dipyridamole echocardiography testing.